ReleaseWire

Global Markets Direct's, 'Incyte Corporation - Product Pipeline Review - 2014', provides an overview of the Incyte Corporation's pharmaceutical research and development focus.

Global Markets Direct's, 'Bavarian Nordic A/S - Product Pipeline Review - 2014', provides an overview of the Bavarian Nordic A/S's pharmaceutical research and development focus.

GlobalData's clinical trial report, "Acute Spinal Cord Injury Global Clinical Trials Review, H1, 2014" provides data on the Acute Spinal Cord Injury clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Acute Spinal Cord Injury. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Acute Spinal Cord Injury. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Global Markets Direct's, 'Crucell N.V. - Product Pipeline Review - 2014', provides an overview of the Crucell N.V.'s pharmaceutical research and development focus.

Global Markets Direct's, 'Hepatic (Liver) Metastasis - Pipeline Review, H1 2014', provides an overview of the Hepatic (Liver) Metastasis's therapeutic pipeline.

Global Markets Direct's, 'MediciNova, Inc. - Product Pipeline Review - 2014', provides an overview of the MediciNova, Inc.'s pharmaceutical research and development focus.

Global Markets Direct's, 'Myotonic Dystrophy - Pipeline Review, H1 2014', provides an overview of the Myotonic Dystrophy's therapeutic pipeline.

GlobalData's clinical trial report, "Dementia Associated With Alzheimer's Disease Global Clinical Trials Review, H1, 2014" provides data on the Dementia Associated With Alzheimer's Disease clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Dementia Associated With Alzheimer's Disease. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Dementia Associated With Alzheimer's Disease. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Global Markets Direct's, 'Cortex Pharmaceuticals, Inc. - Product Pipeline Review - 2014', provides an overview of the Cortex Pharmaceuticals, Inc.'s pharmaceutical research and development focus.

Global Markets Direct's, 'Dry (Atrophic) Macular Degeneration - Pipeline Review, H1 2014', provides an overview of the Dry (Atrophic) Macular Degeneration's therapeutic pipeline.

Amyotrophic lateral sclerosis (ALS) is a rare, but fatal, motor neuron disease (MND) characterized by axonal degeneration and progressive loss of motor neurons. ALS affects both the upper (brain to spinal cord) and lower (brain stem to muscle tissue) motor neurons, gradually reducing a patient's ability to initiate and control muscle movement. Muscle atrophy, starting in the periphery (arms and legs), ultimately leads to complete paralysis after several years of progressive worsening of muscle strength. Respiratory failure is the most common cause of death, as smooth muscle function becomes affected when the disease is in its final stages. The progressively degenerative course of the condition is a great burden for both patients and caregivers, as well as for society. ALS usually affects people age =40 years, and has a worldwide incidence of about two cases per 100,000 population, and a prevalence ranging between four and seven cases per 100,000.

Global Markets Direct's, 'Degenerative Disc Disease - Pipeline Review, H1 2014', provides an overview of the Degenerative Disc Disease's therapeutic pipeline.

Global Markets Direct's, 'Traveler's Diarrhea - Pipeline Review, H1 2014', provides an overview of the Traveler's Diarrhea's therapeutic pipeline.

Global Markets Direct's, 'Tauopathies - Pipeline Review, H1 2014', provides an overview of the Tauopathies's therapeutic pipeline.

Global Markets Direct's, 'Emesis (Vomiting) - Pipeline Review, H1 2014', provides an overview of the Emesis (Vomiting)'s therapeutic pipeline.

Global Markets Direct's, 'Fragile X Syndrome - Pipeline Review, H1 2014', provides an overview of the Fragile X Syndrome's therapeutic pipeline.

Global Markets Direct's, 'Resverlogix Corp. - Product Pipeline Review - 2014', provides an overview of the Resverlogix Corp.'s pharmaceutical research and development focus.

Global Markets Direct's, 'Regulus Therapeutics Inc. - Product Pipeline Review - 2014', provides an overview of the Regulus Therapeutics Inc.'s pharmaceutical research and development focus.

Global Markets Direct's, 'Aerie Pharmaceuticals, Inc. - Product Pipeline Review - 2014', provides an overview of the Aerie Pharmaceuticals, Inc.'s pharmaceutical research and development focus.

GlobalData's clinical trial report, "Dysgeusia (Taste Disorders) Global Clinical Trials Review, H1, 2014" provides data on the Dysgeusia (Taste Disorders) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Dysgeusia (Taste Disorders). It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Dysgeusia (Taste Disorders). This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

GlobalData's clinical trial report, "Chronic Subdural Hematoma Global Clinical Trials Review, H1, 2014" provides data on the Chronic Subdural Hematoma clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Chronic Subdural Hematoma. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Chronic Subdural Hematoma. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Global Markets Direct's, 'Merck KGaA - Product Pipeline Review - 2014', provides an overview of the Merck KGaA's pharmaceutical research and development focus.

Global Markets Direct's, 'Seborrhea - Pipeline Review, H1 2014', provides an overview of the Seborrhea's therapeutic pipeline.

Global Markets Direct's, 'AEterna Zentaris Inc. - Product Pipeline Review - 2014', provides an overview of the AEterna Zentaris Inc. 's pharmaceutical research and development focus.

Global Markets Direct's, 'Ablynx NV - Product Pipeline Review - 2014', provides an overview of the Ablynx NV's pharmaceutical research and development focus.